Myocardial infarction remains one of the leading causes of death worldwide. Following an infarction, part of the heart muscle ...
Recently published Acute Myocardial Infarction Market Insights report includes a comprehensive understanding of current treatment practices, acute myocardial infarction emerging drugs, market share of ...
The acute myocardial infarction market is experiencing steady growth driven by rising global cardiovascular disease prevalence and expanding geriatric populations. Advances in diagnostic technologies ...
Research for other indications is ongoing. In the first trial of microRNA inhibition to treat heart failure, a novel agent ...
Only 50% had optimal BP and HbA1c levels and fewer than one in three patients were within recommended lipid control targets.
Stroke, myocardial infarction and other cardiovascular events are more common in neovascular glaucoma, potentially pointing ...
USA: Cardiogenic shock complicating acute myocardial infarction (AMI-CS) continues to carry a high risk of death, but a new ...
A new cohort study that the sixth-generation High-sensitivity cardiac troponin T (hs-cTnT) assay, when used with a clinically ...
Cardio-cerebral infarction (CCI) is a rare clinical syndrome characterized by the simultaneous or sequential occurrence of acute myocardial infarction (AMI) and acute ischemic stroke (AIS). Despite ...
Dr. Patrick Malecha (Medicine): A 69-year-old man with a history of myocardial infarction, ischemic cardiomyopathy, and an implantable cardioverter–defibrillator (ICD) was evaluated because of dyspnea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results